Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

modified Banxia Xiexin decoction

A traditional Chinese medicine (TCM) formulation, Banxia Xiexin decoction, composed of seven traditional Chinese herbs including Rhizoma Pinelliae (Ban Xia), Radix Scutellariae (Huang Qin), Rhizome Coptidis (Huang Lian), Rhizoma Zingibers (Gan Jiang), Radix Glycyrrhizae (Gan Cao), Fructus Ziziphi Jujubae (Da Zao), and Radix Ginseng (Ren Shen), modified by various Chinese herbal additions, with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration of modified Banxia Xiexin decoction, the active ingredients may promote apoptosis and inhibit tumor cell proliferation through a not yet fully elucidated mechanism. Modified Banxia Xiexin decoction may also inhibit Helicobacter pylori and H. pylori-related inflammation, and protect the gastric mucosa, which may decrease glandular atrophy, intestinal metaplasia, and dysplasia of the gastric mucosa.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:modified BXD
Abbreviation:MBXD
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search